Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chalmers

Showing results (311-320 of 646) with videos related to

Pageof 65
Sort By:
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Development of a competitive PCR method for in vitro and in vivo quantification of herpes simplex virus thymidine kinase and neomycin resistance-expressing cells used in a clinical trialS Maddens, P Tiberghien, E Contassot, et al.
ERJ Open Research|June 10, 2025
Seroprevalence of <i>Bordetella pertussis</i> in patients with COPD in a UK cohortHollian Richardson, Daniela Alferes de Lima Headley, Diane Cassidy, et al.
Clinical Pharmacokinetics|August 17, 2022
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis BronchiectasisJames D Chalmers, Helen Usansky, Christopher M Rubino, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2013
A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infectionsColin Murray, Arlene Shaw, Matthew Lloyd, et al.
Pneumonia (Nathan Qld.)|October 22, 2019
The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in EnglandJ Campling, D Jones, J D Chalmers, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2012
Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasisJames D Chalmers, Maeve P Smith, Brian J McHugh, et al.
Blood|January 3, 2001
Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase geneM I Garin, E Garrett, P Tiberghien, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 16, 2021
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guidelineMegan L Crichton, Pieter C Goeminne, Krizia Tuand, et al.
The Cochrane Database of Systematic Reviews|January 5, 2022
Intermittent prophylactic antibiotics for bronchiectasisSally Spencer, Tim Donovan, James D Chalmers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2019
Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infectionD R VanDevanter, I Gonda, J Dahms, et al.
Pageof 65

Showing results (311-320 of 646) with videos related to

Sort By:
Pageof 65
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Development of a competitive PCR method for in vitro and in vivo quantification of herpes simplex virus thymidine kinase and neomycin resistance-expressing cells used in a clinical trialS Maddens, P Tiberghien, E Contassot, et al.
ERJ Open Research|June 10, 2025
Seroprevalence of <i>Bordetella pertussis</i> in patients with COPD in a UK cohortHollian Richardson, Daniela Alferes de Lima Headley, Diane Cassidy, et al.
Clinical Pharmacokinetics|August 17, 2022
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis BronchiectasisJames D Chalmers, Helen Usansky, Christopher M Rubino, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2013
A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infectionsColin Murray, Arlene Shaw, Matthew Lloyd, et al.
Pneumonia (Nathan Qld.)|October 22, 2019
The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in EnglandJ Campling, D Jones, J D Chalmers, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2012
Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasisJames D Chalmers, Maeve P Smith, Brian J McHugh, et al.
Blood|January 3, 2001
Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase geneM I Garin, E Garrett, P Tiberghien, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 16, 2021
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guidelineMegan L Crichton, Pieter C Goeminne, Krizia Tuand, et al.
The Cochrane Database of Systematic Reviews|January 5, 2022
Intermittent prophylactic antibiotics for bronchiectasisSally Spencer, Tim Donovan, James D Chalmers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2019
Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infectionD R VanDevanter, I Gonda, J Dahms, et al.
Pageof 65